CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 11 No. 7
 

Role of Diet in Cancer Hard to Study, Expert Says

July 1, 1997

Although it is clear that diet plays a role in the etiology of many cancers, making dietary recommendations to reduce risk is highly complicated, if possible at all, according to an international cancer prevention expert.

With many cancers traceable to dietary factors, food is as great a concern as a cause of human cancer as is smoking, Michael J. Hill, PhD, told attendees at the second Strang International Cancer Prevention Conference, co-sponsored by Cornell University Medical College. "Unfortunately, we can give up smoking, but we cannot give up eating," said Dr. Hill, who is Chairman of the European Cancer Prevention Organization.

Cancers tied to dietary factors can be divided into two classes, Dr. Hill said: those of overnutrition, such as breast, endometrial, ovarian, prostate, and colorectal cancers; and those of undernutrition, principally stomach, liver, esophageal, and oropharyngeal cancers. Cancers tied to overnutrition are more common in the West, whereas those related to undernutrition are more common in the East.

One problem with making dietary recommendations to reduce cancer risk is the quality of data available on the role of nutrition in the development of cancer. In view of the long latency period of most cancers, the dietary relationship is not well reflected in prospective studies that span only 5 to 10 years, Dr. Hill pointed out. "We're always looking at late-stage events unless there is a very long follow-up, which is what has been the problem with beta carotene studies," he maintained.

Furthermore, population studies necessarily involve other environmental factors that may skew the data. Longer-range prospective studies are impractical, Dr. Hill said, and retrospective studies are extremely vulnerable to recall bias on the part of the study subjects. Animal studies are of limited relevance, he said, and in vitro studies are even more limited, since "mutagens are not necessarily carcinogens." Substances, that may, in isolation, cause DNA damage to cells in vitro may not do so in the company of other substances, as they are found in food. In vivo, they may not cause cancer at all, since the human organism has many effective repair mechanisms, Dr. Hill explained.

Nonetheless, there are some observations that are consistently strong and can be believed, Dr. Hill said. It makes sense to avoid obesity, since many cancers are related to obesity, and none are protected by it. "Avoiding obesity is safe. It won't give you anything else," he said. Second, consuming fruits and vegetables is beneficial. "From the standpoint of epidemiology, it looks like eating fruits and vegetables is protective, and no causal effects have been observed in a wide range of cancers, including gastric, colorectal, esophageal, oropharyngeal, pancreatic, breast, prostate, bladder, and liver cancers," he said. It is also apparent, he asserted, that cereals and the dietary fiber that they provide are protective against colorectal and probably breast cancer.

The role of fat and meat, however, is less clear, according to Dr. Hill. The recommendation that fat should represent less than 30% of the total daily caloric intake caused a furor, he pointed out, because those European countries with the highest fat intake also have the lowest rate of fat-related cancers. Also, a study in Japan showed meat to be protective against gastric cancer. "What is not clear is whether fat and/or meat intake is a genuine effect or a surrogate marker of a good diet," he said.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
James B. Yu, MD1 , May 17, 2013

A 70-year-old man with a history of localized prostate cancer treated with whole-pelvis radiation therapy with a boost to the prostate, in conjunction with androgen deprivation therapy 7 years prior, presented with lower back pain. A bone scan revealed an area of activity in the sacrum. What is the most likely diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
  • Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
  • Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
  • New AUA Guidelines for Prostate Cancer Screening
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy